QQ客服 官方微博 反馈留言

	Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)
	Nokihara, H.; Lu, S.; Mok, T. S. K.; Nakagawa, K.; Yamamoto, N.; Shi, Y. K.; Zhang, L.; Soo, R. A.; Yang, J. C.; Sugawara, S.
刊名	ANNALS OF ONCOLOGY
	2017
卷号	28期号:11
关键词	docetaxel non-inferiority previously treated NSCLC S-1 phase 3 study
ISSN号	0923-7534
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3612045
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Nokihara, H.,Lu, S.,Mok, T. S. K.,et al. Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)[J]. ANNALS OF ONCOLOGY,2017,28(11).
APA	Nokihara, H..,Lu, S..,Mok, T. S. K..,Nakagawa, K..,Yamamoto, N..,...&Tamura, T..(2017).Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer).ANNALS OF ONCOLOGY,28(11).
MLA	Nokihara, H.,et al."Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)".ANNALS OF ONCOLOGY 28.11(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。